Ticker Details
ABBVIE INC. AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
IPO Date:	December 14, 2012
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$369.65B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.06 | 1.02%
Avg Daily Range (30 D):	$2.44 | 1.14%
Avg Daily Range (90 D):	$2.48 | 1.12%

Institutional Daily Volume
Avg Daily Volume:	6.2M
Avg Daily Volume (30 D):	4.68M
Avg Daily Volume (90 D):	4.65M

Trade Size
Avg Trade Size (Sh.):	103
Avg Trade Size (Sh.) (30 D):	51
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	64,359
Avg Institutional Trade:	$10.66M
Avg Institutional Trade (30 D):	$31.63M
Avg Institutional Trade (90 D):	$29.52M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	19

Market Closing Trades
Avg Closing Trade:	$92.44M
Avg Closing Trade (30 D):	$354.32M
Avg Closing Trade (90 D):	$314.48M
Avg Closing Volume:	787.75K

News

Apr 17, 2026 @ 8:19 PM The Psychedelic Revolution in Mental Healthcare Source: Motley Fool Staff

Apr 16, 2026 @ 5:00 PM Non-Small Cell Lung Cancer Clinical Trial Race Int... Source: Delveinsight

Apr 15, 2026 @ 3:15 PM 3 High-Yielding Dividend Stocks to Buy, Even If Yo... Source: David Jagielski, Cpa

Apr 13, 2026 @ 1:29 PM Eli Lilly's Jaypirca Builds Case With Fourth Posit... Source: Vandana Singh

Apr 13, 2026 @ 10:24 AM S&P 500 Index Dividend Yields Are Teasing All-Time... Source: Eric Volkman

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$2.37	$1.02	$2.37
Diluted EPS	$2.36	$1.02	$2.36
Revenue	$61.16B	$16.62B	$61.16B
Gross Profit	$42.96B	$12.07B	$42.96B
Net Income / Loss	$4.23B	$1.82B	$4.23B
Operating Income / Loss	$15.08B	$4.54B	$15.08B
Cost of Revenue	$18.2B	$4.55B	$18.2B
Net Cash Flow	$-295M	$-400M	$-295M
PE Ratio	88.54